NCT05277051 2025-12-19
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
GlaxoSmithKline
Phase 1 Recruiting
GlaxoSmithKline
H. Lee Moffitt Cancer Center and Research Institute
Gustave Roussy, Cancer Campus, Grand Paris